Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients.

Autor: Nakatani, Shinya1 (AUTHOR), Ishimura, Eiji2 (AUTHOR), Machiba, Yuri1 (AUTHOR), Fujimoto, Kenta1 (AUTHOR), Uedono, Hideki1 (AUTHOR), Tsuda, Akihiro1 (AUTHOR), Mori, Katsuhito2 (AUTHOR), Emoto, Masanori1 (AUTHOR), Inaba, Masaaki1,2 (AUTHOR)
Zdroj: Case Reports in Nephrology & Dialysis. 2020, Vol. 10 Issue 1, p9-17. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje